Immortalization of CD4+ and CD8+ T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone

被引:176
|
作者
Robek, MD
Ratner, L
机构
[1] Washington Univ, Sch Med, Dept Med, Div Mol Oncol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA
关键词
D O I
10.1128/JVI.73.6.4856-4865.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The human T-cell leukemia virus type 1 (HTLV-1) transcriptional trans-activator Tax has been demonstrated to have transforming activity in multiple cell culture and transgenic-mouse models. In addition to activating transcription from the viral long terminal repeat (LTR) through the cyclic AMP response element binding protein/activating transcription factor (CREB/ATF) family of transcription factors, Tax activates the expression of multiple cellular promoters through the NF-kappa B pathway of transcriptional activation. The Tax mutants M22 and M47 have preciously been demonstrated to selectively abrogate the ability of Tax to activate transcription through the NF-kappa B or CREB/ATF pathway, respectively. These mutations were introduced in the tax gene of the ACH functional molecular clone of HTLV-1, and virus produced from the mutant ACH clones was examined for the ability to replicate and immortalize primary human lymphocytes. While virus derived from the clone containing the M47 mutation retained the ability to immortalize T lymphocytes, the M22 mutant lost the ability to immortalize infected cells. These results indicate that activation of the CREB/ATF pathway by Tax is dispensable for the immortalization of T cells by HTLV-1, whereas activation of the NF-kappa B pathway may be critical.
引用
收藏
页码:4856 / 4865
页数:10
相关论文
共 50 条
  • [1] Altered CD4+/CD8+ T-cell ratio in splenocytes of human T-cell leukemia virus type I Tax transgenic mice with inflammatory arthropathy
    Takeo Ohsugi
    Toshio Kumasaka
    Retrovirology, 8 (Suppl 1)
  • [2] CD4+ AND CD8+ T-CELL RESPONSES TO HUMAN PARAINFLUENZA TYPE-1
    SLOBOD, KS
    ALLAN, JE
    FASEB JOURNAL, 1991, 5 (06): : A1770 - A1770
  • [3] T-CELL PROLYMPHOCYTIC LEUKEMIA WITH AN UNUSUAL PHENOTYPE CD4+ CD8+
    KLUINNELEMANS, HC
    GMELIGMEYLING, FHJ
    KOOTTE, AMM
    DENOTTOLANDER, GJ
    TERMIJTELEN, A
    KLUIN, PM
    BEVERSTOCK, GC
    BRAND, A
    CANCER, 1987, 60 (04) : 794 - 803
  • [4] HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I INFECTION OF CD4+ OR CD8+ CYTO-TOXIC T-CELL CLONES RESULTS IN IMMORTALIZATION WITH RETENTION OF ANTIGEN-SPECIFICITY
    FALLER, DV
    CRIMMINS, MAV
    MENTZER, SJ
    JOURNAL OF VIROLOGY, 1988, 62 (08) : 2942 - 2950
  • [5] In vitro peptide immunization of target Tax protein human T-cell leukemia virus type 1-specific CD4+ helper T lymphocytes
    Kobayashi, Hiroya
    Ngato, Toshihiro
    Sato, Keisuke
    Aoki, Naoko
    Kimura, Shoji
    Tanaka, Yuetsu
    Aizawa, Hitoshi
    Tateno, Masatoshi
    Celis, Esteban
    CLINICAL CANCER RESEARCH, 2006, 12 (12) : 3814 - 3822
  • [6] Towards a cellular definition of CD8+ T-cell memory:: the role of CD4+ T-cell help in CD8+ T-cell responses
    Rocha, B
    Tanchot, C
    CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (03) : 259 - 263
  • [7] CHARACTERISTICS OF VIRUS-SPECIFIC CD4+ AND CD8+ T-CELL MEMORY
    DOHERTY, PC
    TOPHAM, D
    TRIPP, R
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 59 - 59
  • [8] T-CELL SUBSET RESPONSES TO ALLOGENEIC ENDOTHELIUM - PROLIFERATION OF CD8+ BUT NOT CD4+ LYMPHOCYTES
    LODGE, PA
    HAISCH, CE
    TRANSPLANTATION, 1993, 56 (03) : 656 - 661
  • [9] From crucial to negligible: Functional CD8+ T-cell responses and their dependence on CD4+ T-cell help
    Wiesel, Melanie
    Oxenius, Annette
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2012, 42 (05) : 1080 - 1088
  • [10] A NOVEL SERINE PROTEINASE (HUTSP) ISOLATED FROM A CLONED HUMAN CD8+ CYTOLYTIC T-CELL LINE IS EXPRESSED AND SECRETED BY ACTIVATED CD4+ AND CD8+ LYMPHOCYTES
    FRUTH, U
    SINIGAGLIA, F
    SCHLESIER, M
    KILGUS, J
    KRAMER, MD
    SIMON, MM
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (11) : 1625 - 1633